Parkinson’s disease is associated with increased serum levels of macrophage migration inhibitory factor

Alessandra Nicoletti(University of Catania), Ferdinando Nicoletti(University of Catania), Mario Zappia(University of Catania), Katia Mangano(University of Catania), Giulia Donzuso(University of Catania), Valeria Dibilio(University of Catania), S Caponnetto(University of Catania), Klaus Bendtzen(Rigshospitalet), Paolo Fagone(University of Catania)
Cytokine
May 10, 2011
10.1016/j.cyto.2011.03.027
Cited by 48

Related Papers

Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
|Aging|2011|707
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495